Literature DB >> 25054660

Magnetic resonance spectroscopic imaging in the era of pseudoprogression and pseudoresponse in glioblastoma patient management.

Hyunsuk Shim1, Chad A Holder, Jeffrey J Olson.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 25054660      PMCID： PMC4281960          DOI： 10.2217/cns.13.39

Source DB:  PubMed          Journal:  CNS Oncol        ISSN： 2045-0907


× No keyword cloud information.
  14 in total

1.  Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group.

Authors:  Patrick Y Wen; David R Macdonald; David A Reardon; Timothy F Cloughesy; A Gregory Sorensen; Evanthia Galanis; John Degroot; Wolfgang Wick; Mark R Gilbert; Andrew B Lassman; Christina Tsien; Tom Mikkelsen; Eric T Wong; Marc C Chamberlain; Roger Stupp; Kathleen R Lamborn; Michael A Vogelbaum; Martin J van den Bent; Susan M Chang
Journal:  J Clin Oncol       Date:  2010-03-15       Impact factor: 44.544

2.  Early prediction of response to Vorinostat in an orthotopic rat glioma model.

Authors:  Li Wei; Samuel Hong; Younghyoun Yoon; Scott N Hwang; Jaekeun C Park; Zhaobin Zhang; Jeffrey J Olson; Xiaoping P Hu; Hyunsuk Shim
Journal:  NMR Biomed       Date:  2012-02-02       Impact factor: 4.044

3.  Human brain tumors: spectral patterns detected with localized H-1 MR spectroscopy.

Authors:  H Kugel; W Heindel; R I Ernestus; J Bunke; R du Mesnil; G Friedmann
Journal:  Radiology       Date:  1992-06       Impact factor: 11.105

Review 4.  Imaging of brain tumors: MR spectroscopy and metabolic imaging.

Authors:  Alena Horská; Peter B Barker
Journal:  Neuroimaging Clin N Am       Date:  2010-08       Impact factor: 2.264

5.  Rebound tumour progression after the cessation of bevacizumab therapy in patients with recurrent high-grade glioma.

Authors:  Richard M Zuniga; Roy Torcuator; Rajan Jain; John Anderson; Thomas Doyle; Lonni Schultz; Tom Mikkelsen
Journal:  J Neurooncol       Date:  2010-02-12       Impact factor: 4.130

Review 6.  Depression in cerebral glioma patients: a systematic review of observational studies.

Authors:  Alasdair G Rooney; Alan Carson; Robin Grant
Journal:  J Natl Cancer Inst       Date:  2010-11-24       Impact factor: 13.506

7.  Inositol treatment raises CSF inositol levels.

Authors:  J Levine; A Rapaport; L Lev; Y Bersudsky; O Kofman; R H Belmaker; J Shapiro; G Agam
Journal:  Brain Res       Date:  1993-11-05       Impact factor: 3.252

8.  Human brain tumors: assessment with in vivo proton MR spectroscopy.

Authors:  D Ott; J Hennig; T Ernst
Journal:  Radiology       Date:  1993-03       Impact factor: 11.105

9.  Mapping of brain metabolite distributions by volumetric proton MR spectroscopic imaging (MRSI).

Authors:  A A Maudsley; C Domenig; V Govind; A Darkazanli; C Studholme; K Arheart; C Bloomer
Journal:  Magn Reson Med       Date:  2009-03       Impact factor: 4.668

10.  A measure to evaluate deformable registration fields in clinical settings.

Authors:  Eduard Schreibmann; Paul Pantalone; Anthony Waller; Tim Fox
Journal:  J Appl Clin Med Phys       Date:  2012-09-06       Impact factor: 2.102
View more
  6 in total

Review 1.  Application of 7T MRS to High-Grade Gliomas.

Authors:  L McCarthy; G Verma; G Hangel; A Neal; B A Moffat; J P Stockmann; O C Andronesi; P Balchandani; C G Hadjipanayis
Journal:  AJNR Am J Neuroradiol       Date:  2022-05-26       Impact factor: 4.966

Review 2.  Metabolic and physiologic magnetic resonance imaging in distinguishing true progression from pseudoprogression in patients with glioblastoma.

Authors:  Sanjeev Chawla; Sultan Bukhari; Omar M Afridi; Sumei Wang; Santosh K Yadav; Hamed Akbari; Gaurav Verma; Kavindra Nath; Mohammad Haris; Stephen Bagley; Christos Davatzikos; Laurie A Loevner; Suyash Mohan
Journal:  NMR Biomed       Date:  2022-03-15       Impact factor: 4.478

3.  Glutamate Is a Noninvasive Metabolic Biomarker of IDH1-Mutant Glioma Response to Temozolomide Treatment.

Authors:  Elavarasan Subramani; Marina Radoul; Chloe Najac; Georgios Batsios; Abigail R Molloy; Donghyun Hong; Anne Marie Gillespie; Romelyn Delos Santos; Pavithra Viswanath; Joseph F Costello; Russell O Pieper; Sabrina M Ronen
Journal:  Cancer Res       Date:  2020-09-21       Impact factor: 12.701

Review 4.  Use of high-resolution volumetric MR spectroscopic imaging in assessing treatment response of glioblastoma to an HDAC inhibitor.

Authors:  Hyunsuk Shim; Li Wei; Chad A Holder; Ying Guo; Xiaoping P Hu; Andrew H Miller; Jeffrey J Olson
Journal:  AJR Am J Roentgenol       Date:  2014-08       Impact factor: 3.959

Review 5.  Emerging MRI Techniques to Redefine Treatment Response in Patients With Glioblastoma.

Authors:  Fabrício Guimarães Gonçalves; Sanjeev Chawla; Suyash Mohan
Journal:  J Magn Reson Imaging       Date:  2020-03-19       Impact factor: 4.813

6.  Three-dimensional echo planar spectroscopic imaging for differentiation of true progression from pseudoprogression in patients with glioblastoma.

Authors:  Gaurav Verma; Sanjeev Chawla; Suyash Mohan; Sumei Wang; MacLean Nasrallah; Sulaiman Sheriff; Arati Desai; Steven Brem; Donald M O'Rourke; Ronald L Wolf; Andrew A Maudsley; Harish Poptani
Journal:  NMR Biomed       Date:  2018-12-17       Impact factor: 4.044
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.